News for Innate Pharma SA (IDD.BE)

MARSEILLE, France, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16...

Marseille, Feb. 17, 2021 -- Innate Pharma SA announced today that members of its senior management team are scheduled to participate in the following upcoming virtual investor conference: ... | February 17, 2021

MARSEILLE, France, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (OTC:IPHYF, NASDAQ:IPHA) ("Innate" or the "Company") announced today that members of ...

TELLOMAK trial progresses as cohort 2 of KIR3DL2-expressing mycosis fungoides patients advances to Stage 2 earlier than anticipatedCompany to init...

MARSEILLE, France, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the ...

MARSEILLE, France, Jan. 04, 2021 -- Innate Pharma SA announced today that members of its senior management team are scheduled to participate in the following upcoming virtual investor... | January 4, 2021